As of Feb 4, 2025, the NRC stock has a P/E ratio of 14.41. The calculation is based on the latest EPS of $1.13 and the stock price of $16.28 per share. A decrease of 44% has been observed in the PE ratio compared to its average of 25.6 of the past four quarters.
The mean historical PE ratio of National Research over the last ten years is 37.04. The current 14.41 price-to-earnings ratio is 61% less than the historical average. Analyzing the last ten years, NRC's PE ratio reached its highest point in the Sep 2017 quarter at 71.13, with a price of $37.7 and an EPS of $0.53. The Jun 2024 quarter saw the lowest point at 18.97, with a price of $22.95 and an EPS of $1.21.
Maximum annual increase: 78.11% in 2017
Maximum annual decrease: -48.88% in 2018
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2023 | 31.4 | 7.76% | $39.56 | $1.26 |
2022 | 29.14 | 3.19% | $37.3 | $1.28 |
2021 | 28.24 | -2.25% | $41.52 | $1.47 |
2020 | 28.89 | -43.04% | $42.75 | $1.48 |
2019 | 50.72 | 43.64% | $65.94 | $1.3 |
2018 | 35.31 | -48.88% | $38.14 | $1.08 |
2017 | 69.07 | 78.11% | $37.3 | $0.54 |
2016 | 38.78 | 1.54% | $19 | $0.49 |
2015 | 38.19 | 20.09% | $16.04 | $0.42 |
2014 | 31.8 | -37.48% | $13.99 | $0.44 |
2013 | 50.86 | 4.16% | $18.82 | $0.37 |
2012 | 48.83 | 9.46% | $18.07 | $0.37 |
2011 | 44.61 | 68.02% | $12.94 | $0.29 |
2010 | 26.55 | 65.42% | $11.42 | $0.43 |
2009 | 16.05 | -38.48% | $6.9 | $0.43 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Sep 2024 | 20.23 | 6.64% | $22.86 | $1.13 |
Jun 2024 | 18.97 | -40.14% | $22.95 | $1.21 |
Mar 2024 | 31.69 | 0.92% | $39.61 | $1.25 |
Dec 2023 | 31.4 | -17.19% | $39.56 | $1.26 |
Sep 2023 | 37.92 | 3.72% | $44.37 | $1.17 |
Jun 2023 | 36.56 | 2.52% | $43.51 | $1.19 |
Mar 2023 | 35.66 | 22.37% | $43.51 | $1.22 |
Dec 2022 | 29.14 | 1.78% | $37.3 | $1.28 |
Sep 2022 | 28.63 | 6.95% | $39.8 | $1.39 |
Jun 2022 | 26.77 | -2.08% | $38.28 | $1.43 |
Mar 2022 | 27.34 | -3.19% | $39.65 | $1.45 |
Dec 2021 | 28.24 | -4.92% | $41.52 | $1.47 |
Sep 2021 | 29.7 | -8.11% | $42.17 | $1.42 |
Jun 2021 | 32.32 | -4.75% | $45.9 | $1.42 |
Mar 2021 | 33.93 | 17.45% | $46.83 | $1.38 |
NRC's current PE ratio is under its 3, 5 and 10-year averages.
Stock name | PE ratio | Market cap |
---|---|---|
NRC National Research Corp | 14.41 | $382.19M |
OMIC Singular Genomics Systems Inc | N/A | $49.73M |
NWBO Northwest Biotherapeutics Inc | N/A | $375.48M |
The price to earnings ratio for NRC stock is 14.41 as of Feb 4, 2025.
Over the last 3 years, the average PE ratio for NRC stock is 29.48.
Over the last 5 years, the average PE ratio for NRC stock is 30.59.
Over the last ten years, the quarterly PE ratio reached its highest level at 71.13 in the Sep 2017 quarter.
NRC's current price to earnings ratio is 61% below its 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Feb 4, 2025), National Research's share price is $16.28. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $1.13. Therefore, National Research's price to earnings ratio for today is 14.41. PE RATIO(14.41) = STOCK PRICE($16.28) / TTM EPS($1.13)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.